Acumen Pharmaceuticals has recently priced its $130 million offering. Which aims to strengthen the company’s financial position and support its…
Browsing: pharmaceutical industry.
Roche’s Alzheimer’s drug Gantenerumab has experienced a major setback. It failed phase 3 clinical trials, resulting in financial losses for…
MorphoSys AG, a leading biopharmaceutical company, has announced an upward revision to its guidance for the second quarter and full…
MorphoSys, a German biopharmaceutical company, has reported its fourth-quarter financial results, showing signs of improvement and reaffirming its guidance for…